08.21.26 -- Supporting Digital Documentation With AI

A fully integrated single‑site model unifies development, manufacturing, formulation, fill‑finish, and quality oversight to reduce handoff risk and speed progression from API to sterile drug product.

Efficient CDMO audits require planning, clear communication, and real-time documentation to manage risks, avoid pitfalls, and strengthen compliance while protecting profitability and fostering partnerships.

Poor scoping kills drug delivery device programs before they start. Learn how to define the right problem, assess risk early, and set boundaries that protect your timeline and budget.

Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.

Multicomponent filling and sterilizing systems represent advantages for vaccine production. See how B/F/S systems can be adapted for vaccine production without incurring any product degradation.

Self-driving labs bring automation and AI together to transform research. Assimilate how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.

Maintaining a dynamic, digital defect library is essential for modern sterile manufacturing. Unveil how this approach helps ensure consistency in batch disposition and supports regulatory compliance.

Small changes in mobile phase, temperature, and column chemistry can affect the detection of GLP-1 peptide impurities. Uncover which conditions improve resolution for challenging peptide analyses.

qPCR workflows are vital but prone to common errors. Improve the precision and reliability of your gene expression data by mastering key strategies to overcome frequent experimental pitfalls.

Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.

Observe how a compound library, designed for chemical diversity and lead-like properties, uses filtering to improve hit discovery, speed hit-to-lead development, and boost small molecule drug discovery.

In silico modeling cut through formulation guesswork for a compound with 0.015 mg/mL solubility, delivering an 8× Cmax and 5× AUC improvement and Phase I progression.

Growing use of large‑volume subcutaneous therapies is increasing demand for wearable injectors that reduce user error, simplify preparation, and enhance safety through human‑factors‑focused design.

Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.

Prefilled syringes improve lipid nanoparticle dosing accuracy and administration. Advanced containment solutions with cross-linked coatings preserve stability and accelerate development timelines.

Explore the viscosity-driven limits of dye ingress testing, translating qualitative constraints into a quantitative feasibility boundary shaped by defect size, pressure behavior, and plunger mechanics.

Review the pros and cons of soluble and insoluble processes, experiences with isolating, solubilizing, and properly re-folding, and strategies and innovation to improve insoluble processes.

To meet immediate vaccine demand, aseptic manufacturing capacity must increase quickly. This means environmental monitoring programs must adapt rapidly as well. Thoughtful planning can help.